Trump News

Questions swirled on Wednesday after President Donald Trump's press secretary turned in her resignation letter.

Karoline Leavitt, who has served as Trump's chief press liaison throughout his second administration, announced that she will be leaving the administration at the end of the month to spend more time with her family. Leavitt gave birth to a baby daughter in May and returned from maternity leave in July.

President Donald Trump's longtime press secretary, Karoline Leavitt, announced on Wednesday that she will step down from her role at the end of the month — but there was something off about her public statement.

In a lengthy post on social media, Leavitt explained that "Being a mother and welcoming a new baby while working in one of the most demanding jobs in the world has been the most rewarding yet challenging season of my life, to say the least. The truth is since returning to the White House after the birth of my daughter, I have felt in my heart that I cannot be the best mom my two young children deserve while devoting the constant time, energy, and attention required of the White House Press Secretary — and that is why I have ultimately made the bittersweet decision to depart the White House and embark on a new chapter in my life."

New Immigration and Customs Enforcement plans to employ electroshock gloves to incapacitate suspects were met with horror by a CNN panel on Wednesday.

Anchor Brianna Keilar raised her own concerns to correspondent Brian Todd, noting that "first off, you can't always tell if someone's pregnant ... especially in cold weather when people are all rugged up with coats. We've seen how sometimes you can't always tell if someone's disabled."

A Fort Worth activist who cursed out the Republican-majority Tarrant County Commissioners Court over a plan to gut polling sites was arrested in the middle of the night.

Efrin "EJ" Carrion, a Fort Worth activist and host of the 817 Podcast, was booked into Tarrant County Jail early Wednesday on a charge of disrupting a meeting. It is a Class B misdemeanor, meaning a low-level criminal offense.

Treasury Secretary Scott Bessent seems to have cooked up a scheme to keep a "cash spigot" flowing, one that may wreak havoc on the international economy if it backfires, according to a new column.

The Guardian's editorial board argued on Wednesday that Bessent's plan to buy up a large volume of Japanese Yen may help stabilize markets in the short term. However, they warned that it is likely to lead to a massive issue if the plan goes sideways.

Health and Human Services Secretary Robert F. Kennedy Jr. is promising the federal government's first official definition of ultra-processed foods.

There's just one problem, reported Nicholas Florko for The Atlantic: nobody, including scientists who study the category, actually agrees on what counts.

Immigration and Customs Enforcement may soon be equipped with electroshock gloves to subdue detainees — but the proposal has already drawn legal threats.

In a press conference on Wednesday, leaders in New York State vowed any use of this weapon in their jurisdiction will be met with swift legal retribution.

Gas prices in the United States hit a dubious milestone this week, as for the first time in at least a quarter-century, the national average has stayed above $4 a gallon this deep into the year.

The average price of a gallon of regular sat at $4.03 on Wednesday, according to AAA. While on its own, the figure is unremarkable, dropping from $4.08 a week ago and only modestly above the $3.87 recorded a month earlier. But experts noted that it stands out because of the calendar.

A Trump-aligned candidate for governor in Ohio has long touted his biotech experience, but much of his success may have been due to his mom doctoring data, according to a new report.

Oligarchy Watch reported on Wednesday that Vivek Ramaswamy's mom, Geetha, who worked with her son at biotech firm Axovant despite having no experience running clinical trials, may have manipulated data about the effectiveness of the drug intepirdine, which Axovant purchased in its efforts to develop a treatment for Alzheimers.